What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?

Current evidence indicates no significant difference in major bleeding risk between ticagrelor and clopidogrel in patients with peripheral artery disease, though ticagrelor may have a higher incidence of minor bleeding.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24217409
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Antiplatelet Therapy and Cardiovascular Diseases
article

What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?

Tripdatabase
article en

Abstract

Current evidence indicates no significant difference in major bleeding risk between ticagrelor and clopidogrel in patients with peripheral artery disease, though ticagrelor may have a higher incidence of minor bleeding.

Zenodo (CERN European Organization for Nuclear Research)
Antiplatelet Therapy and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon